207 related articles for article (PubMed ID: 18627202)
1. High-throughput study of phenytoin solid dispersions: formulation using an automated solvent casting method, dissolution testing, and scaling-up.
Barillaro V; Pescarmona PP; Van Speybroeck M; Thi TD; Van Humbeeck J; Vermant J; Augustijns P; Martens JA; Van Den Mooter G
J Comb Chem; 2008; 10(5):637-43. PubMed ID: 18627202
[TBL] [Abstract][Full Text] [Related]
2. Method for screening of solid dispersion formulations of low-solubility compounds--miniaturization and automation of solvent casting and dissolution testing.
Shanbhag A; Rabel S; Nauka E; Casadevall G; Shivanand P; Eichenbaum G; Mansky P
Int J Pharm; 2008 Mar; 351(1-2):209-18. PubMed ID: 18054181
[TBL] [Abstract][Full Text] [Related]
3. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
4. Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersions.
Muhrer G; Meier U; Fusaro F; Albano S; Mazzotti M
Int J Pharm; 2006 Feb; 308(1-2):69-83. PubMed ID: 16324806
[TBL] [Abstract][Full Text] [Related]
5. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties.
Zimmermann A; Millqvist-Fureby A; Elema MR; Hansen T; Müllertz A; Hovgaard L
Eur J Pharm Biopharm; 2009 Jan; 71(1):109-16. PubMed ID: 18619536
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
Ye G; Wang S; Heng PW; Chen L; Wang C
Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
[TBL] [Abstract][Full Text] [Related]
7. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
Vandecruys R; Peeters J; Verreck G; Brewster ME
Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
[TBL] [Abstract][Full Text] [Related]
8. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS).
Atef E; Belmonte AA
Eur J Pharm Sci; 2008 Nov; 35(4):257-63. PubMed ID: 18706499
[TBL] [Abstract][Full Text] [Related]
9. Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material.
Dai WG; Dong LC; Li S; Pollock-Dove C; Chen J; Mansky P; Eichenbaum G
Int J Pharm; 2007 May; 336(1):1-11. PubMed ID: 17178444
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
Kocbek P; Baumgartner S; Kristl J
Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B
Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682
[TBL] [Abstract][Full Text] [Related]
12. Determination of surface-adsorbed excipients of various types on drug particles prepared by antisolvent precipitation using HPLC with evaporative light scattering detection.
Zimmermann A; Elema MR; Hansen T; Müllertz A; Hovgaard L
J Pharm Biomed Anal; 2007 Aug; 44(4):874-80. PubMed ID: 17531425
[TBL] [Abstract][Full Text] [Related]
13. Multiscale Computational Modeling of the Nanostructure of Solid Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin.
Huang W; Mandal T; Larson RG
Mol Pharm; 2017 Oct; 14(10):3422-3435. PubMed ID: 28829134
[TBL] [Abstract][Full Text] [Related]
14. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate.
Higashi K; Hayashi H; Yamamoto K; Moribe K
Int J Pharm; 2015 Oct; 494(1):9-16. PubMed ID: 26253374
[TBL] [Abstract][Full Text] [Related]
15. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
Dai WG; Pollock-Dove C; Dong LC; Li S
Adv Drug Deliv Rev; 2008 Mar; 60(6):657-72. PubMed ID: 18222563
[TBL] [Abstract][Full Text] [Related]
16. Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing.
Mansky P; Dai WG; Li S; Pollock-Dove C; Daehne K; Dong L; Eichenbaum G
J Pharm Sci; 2007 Jun; 96(6):1548-63. PubMed ID: 17094139
[TBL] [Abstract][Full Text] [Related]
17. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers.
Friedrich H; Fussnegger B; Kolter K; Bodmeier R
Eur J Pharm Biopharm; 2006 Feb; 62(2):171-7. PubMed ID: 16275049
[TBL] [Abstract][Full Text] [Related]
18. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug.
Tran TT; Tran PH; Lee BJ
Eur J Pharm Biopharm; 2009 May; 72(1):83-90. PubMed ID: 19141319
[TBL] [Abstract][Full Text] [Related]
19. Maximizing automation in LC/MS high-throughput analysis and purification.
Koppitz M; Brailsford A; Wenz M
J Comb Chem; 2005; 7(5):714-20. PubMed ID: 16153066
[TBL] [Abstract][Full Text] [Related]
20. Encapsulation of poorly water-soluble drugs into organic nanotubes for improving drug dissolution.
Moribe K; Makishima T; Higashi K; Liu N; Limwikrant W; Ding W; Masuda M; Shimizu T; Yamamoto K
Int J Pharm; 2014 Jul; 469(1):190-6. PubMed ID: 24746412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
